These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18075845)

  • 1. Polycystic ovary syndrome: a follow-up study on diabetes mellitus, cardiovascular disease and malignancy 15-25 years after ovarian wedge resection.
    Lunde O; Tanbo T
    Gynecol Endocrinol; 2007 Dec; 23(12):704-9. PubMed ID: 18075845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
    Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease risk factors in polycystic ovary syndrome.
    Dokras A
    Semin Reprod Med; 2008 Jan; 26(1):39-44. PubMed ID: 18181081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women.
    Talbott EO; Zborowski JV; Rager JR; Kip KE; Xu X; Orchard TJ
    J Womens Health (Larchmt); 2007 Mar; 16(2):191-7. PubMed ID: 17388735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
    Thomann R; Rossinelli N; Keller U; Tirri BF; De Geyter C; Ruiz J; Kränzlin M; Puder JJ
    Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk in women with polycystic ovary syndrome.
    Cho LW; Atkin SL
    Minerva Endocrinol; 2007 Dec; 32(4):263-73. PubMed ID: 18091663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. To determine whether first-degree male relatives of women with polycystic ovary syndrome are at higher risk of developing cardiovascular disease and type II diabetes mellitus.
    Hunter A; Vimplis S; Sharma A; Eid N; Atiomo W
    J Obstet Gynaecol; 2007 Aug; 27(6):591-6. PubMed ID: 17896258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN; Merchant R
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term consequences of polycystic ovary syndrome on cardiovascular risk.
    Rizzo M; Berneis K; Spinas G; Rini GB; Carmina E
    Fertil Steril; 2009 Apr; 91(4 Suppl):1563-7. PubMed ID: 18976752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of wedge resection of the ovary as a cause for mechanical sterility.
    Weinstein D; Polishuk WZ
    Surg Gynecol Obstet; 1975 Sep; 141(3):417-8. PubMed ID: 1162571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance.
    Bethea SW; Nestler JE
    Panminerva Med; 2008 Dec; 50(4):295-304. PubMed ID: 19078870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of ovarian surgery in polycystic ovary syndrome.
    Farquhar CM
    Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):789-802. PubMed ID: 15380147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.
    Brzozowska MM; Ostapowicz G; Weltman MD
    J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic ovarian syndrome: the next cardiovascular dilemma in women?
    Srikanthan P; Korenman S; Davis S
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):611-31, x. PubMed ID: 16959589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and the polycystic ovary syndrome.
    Magnotti M; Futterweit W
    Med Clin North Am; 2007 Nov; 91(6):1151-68, ix-x. PubMed ID: 17964914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endocrinological assessment, treatment and follow-up on polycystic ovary syndrome].
    Glintborg D; Rungby J; Eskildsen P; Hermann AP; Stecher CW; Andersen M;
    Ugeskr Laeger; 2010 Jan; 172(3):196-9. PubMed ID: 20089209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycystic ovary syndrome and cardiovascular disease.
    Loverro G
    Minerva Endocrinol; 2004 Sep; 29(3):129-38. PubMed ID: 15282445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of antiovarian antibodies after laparoscopic ovarian electrocauterization in patients with polycystic ovary syndrome.
    Alborzi S; Tavazoo F; Dehaghani AS; Ghaderi A; Alborzi S; Alborzi M
    Fertil Steril; 2009 Apr; 91(4):1159-63. PubMed ID: 18439597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycystic ovarian syndrome: an evidence-based approach to evaluation and management of diabetes and cardiovascular risks for today's clinician.
    Lorenz LB; Wild RA
    Clin Obstet Gynecol; 2007 Mar; 50(1):226-43. PubMed ID: 17304038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.
    Glueck CJ; Goldenberg N; Sieve L; Wang P
    Metabolism; 2008 Jul; 57(7):954-60. PubMed ID: 18555837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.